Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A U Neumann

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Nature|January 12, 1995
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionD D Ho, A U Neumann, A S Perelson, et al.
Journal of Viral Hepatitis|September 13, 2003
Slow viral dynamics of hepatitis C virus genotype 4P Halfon, A U Neumann, M Bourlière, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaN P Lam, A U Neumann, D R Gretch, et al.
Genes and Immunity|February 24, 2001
Evidence for recent selection of the CCR5-delta 32 deletion from differences in its frequency between Ashkenazi and Sephardi JewsS Maayan, L Zhang, E Shinar, et al.
Journal of Viral Hepatitis|June 9, 2012
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirinH Guedj, J Guedj, F Negro, et al.
Journal of Virology|October 6, 1997
Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDSE L Delwart, H Pan, H W Sheppard, et al.
AIDS (London, England)|July 9, 1999
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study GroupA U Neumann, R Tubiana, V Calvez, et al.
Science (New York, N.Y.)|November 8, 1996
Response: HIV-1 Evolution and Disease ProgressionS M Wolinsky, K J Kunstman, J T Safrit, et al.
Gastroenterology|April 21, 2001
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2aS Zeuzem, E Herrmann, J H Lee, et al.
The Journal of Infectious Diseases|May 9, 2001
RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progressionW A Paxton, A U Neumann, S Kang, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Nature|January 12, 1995
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionD D Ho, A U Neumann, A S Perelson, et al.
Journal of Viral Hepatitis|September 13, 2003
Slow viral dynamics of hepatitis C virus genotype 4P Halfon, A U Neumann, M Bourlière, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaN P Lam, A U Neumann, D R Gretch, et al.
Genes and Immunity|February 24, 2001
Evidence for recent selection of the CCR5-delta 32 deletion from differences in its frequency between Ashkenazi and Sephardi JewsS Maayan, L Zhang, E Shinar, et al.
Journal of Viral Hepatitis|June 9, 2012
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirinH Guedj, J Guedj, F Negro, et al.
Journal of Virology|October 6, 1997
Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDSE L Delwart, H Pan, H W Sheppard, et al.
AIDS (London, England)|July 9, 1999
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study GroupA U Neumann, R Tubiana, V Calvez, et al.
Science (New York, N.Y.)|November 8, 1996
Response: HIV-1 Evolution and Disease ProgressionS M Wolinsky, K J Kunstman, J T Safrit, et al.
Gastroenterology|April 21, 2001
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2aS Zeuzem, E Herrmann, J H Lee, et al.
The Journal of Infectious Diseases|May 9, 2001
RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progressionW A Paxton, A U Neumann, S Kang, et al.
Pageof 5